F20-F29 F30-F39 F40-F48 F60-F69 F10-F19
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Family with at least one psychiatrically ill parent and at least one minor child between the age of 3 and 19 years. 2. Consent to participate in the study. 3. Sufficient knowlede of the German language of parents and children.
Exclusion criteria
Exclusion criteria: 1. Severe psychiatric disorders and impairments with acute symptoms such as suicidal tendencies, massive self-injurious behaviour, acute psychotic symptoms etc., making a stationary treatment inevitable and making a ambulatory intervention appear contraindicated (these patients are placed in stationary treatment) 2. Children with severe symptoms in the control group will be placed at a participating psychotherapist. Nevertheless, they stay in the control group (as TAU).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome parameter is the children's psychiatric symptomatology. It will be assessed, in both groups (intervention group and control group), by an external independent interview (Kiddie-SADS, Kaufman et al., 1996) at the beginning and after six, 12 and 18 months. The Kiddie-SADS interview will be conducted by a trained rater external to the project (observer-blind rater). The psychiatric disorders of the children will further be assessed by the CBCL ("Child behaviour checklist", Achenbach, 1991), the YSR ("Youth self report", Achenbach, 1991) and the SGKJ ("Skala zur Gesamtbeurteilung von Kindern und Jugendlichen", a scale for the overall assessment of children and adolescents, Steinhausen, 1985). | — |
Secondary
| Measure | Time frame |
|---|---|
| A key secondary endpoint is the health related quality of life which will be measured by the "Kidscreen" (Ravens-Sieberer et al., 2006) for children and by the "EQ-5D" (Brooks, Rabon & de Charro, 2003; Hinz, Klaiberg, Brähler & König, 2006) for parents. Further secondary endpoints will be assessed as follows: the symptomatology of the parents will be assessed by the BSI ("Brief Symptom Inventory", Franke, 2000) and by the PHQ ("Patient Health Questionnaire"; Löwe, Spitzer, Zipfel, & Herzog, 2002) as well as during treatment by the SKID ("Strukturiertes klinisches Interview für DSM-IV", a structured clinical interview for DSM-IV, Wíttchen, Zaudig & Fydrich, 1997), the coping with the disorder will be assessed by the FKV ("Freiburger Fragebogen zur Krankheitsbewältigung", Muthny, 1989), family relations and family functioning by the FB-A ("Allgemeiner Familienfragebogen", Cierpka & Frevert, 1995) and social support will be measured by the OSSQ ("Oslo Social Support Questionnaire", Dalgaard, 1996). These measurements will take place at the beginning, after six, 12 and 18 months. The objectives of the treatment (at the beginning) and the achievement of objectives (at the end of treatment and after the follow-up period of 1 year) will be asssessed using ad-hoc items. For the evaluation of the treatment, the FBB ("Fragebogen zur Beurteilung der Behandlung", Mattejat & Remschmidt, 1999) will be used (at the end of treatment and after the follow-up period of 1 year). The health economic assessment of treatment costs for children will be conducted by the German version of the CAMHSRI ("Children and adolescent mental health services receipt inventory", Kilian et al., 2009). Treatment costs for parents will be assessed by the German version of the CSSRI ("Client Socioeconomic and Services Receipt Inventory", Roick et al., 2001). The health economic measurements will be conducted at four points in time: at the beginning, after six, 12 and 18 months. | — |
Countries
Germany, Switzerland
Contacts
Universitätsklinikum Hamburg-EppendorfZentrum für psychosoziale MedizinKlinik für Kinder- und Jugendpsychiatrie, -psychotherapie und -psychosomatik